Skip to content

Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study

Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02928549
Enrollment
24
Registered
2016-10-10
Start date
2016-09-22
Completion date
2019-08-26
Last updated
2019-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer

Keywords

interviews, 16-1378

Brief summary

The purpose of this study is to explore the experiences of Black women who receive care for ovarian cancer at Memorial Sloan Kettering Cancer Center, or MSK for short. The study consists of interviews with Black women who recently obtained some part of their ovarian cancer care at MSK.

Interventions

BEHAVIORALsemi-structured interviews

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participant must have been diagnosed with ovarian, fallopian tube or primary peritoneal cancer and treated by an MSK physician. * Participants must be able to provide verbal informed consent. * Participants must be 18 years of age or older. * Participants must self-identify as Black/African American. * Participant must be able to understand and speak in English

Exclusion criteria

* Inability or refusal to identify race/ethnicity. * Presence or development of a physical, cognitive or psychiatric deficit resulting in an inability to provide meaningful informed consent or to understand the study or complete the interview.

Design outcomes

Primary

MeasureTime frameDescription
accessing care1 yearThe study team will review and code the interview transcripts through a process of independent and collaborative thematic content analysis,\[15-18\] using ATLAS.ti (a qualitative data analysis software package) to facilitate the analysis process.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026